JPRN-UMIN000035565已完成未知
Carbon-ion radiotherapy for Cholangiocarcinoma: A multi-institutional study by the Japan Carbon-ion radiation oncology group (J-CROS) - Carbon-ion radiotherapy for Cholangiocarcinoma:
Gunma University Heavy Ion Medical center0 个研究点目标入组 56 人开始时间: 2019年1月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 56
研究概览
简要总结
The median survival was 14.8 (range, 2.1-129.2) months, and the 1- and 2-year OS rates were 69.7% and 40.9%, respectively.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) previous treatment for the target tumor by other radiation therapies or surgery; 2) tumor invasion of the digestive tract; 3) an untreatable ascites; 4) other active malignant tumors besides the cholangiocarcinoma to be treated; 5) severe comorbidity such as uncontrolled diabetes mellitus, renal failure, or cardiac failure; 6) a serious medical or psychological condition precluding safe administration of treatment.
研究者
相似试验
已完成
不适用
Phase II trial of carbon-ion radiotherapy with Gemcitabine for locally advanced pancreatic cancer (GUNMA1301)ocally advanced pancreatic cancerJPRN-UMIN000012296Gunma University Heavy Ion Medical Center21
已完成
不适用
Carbon ion radiotherapy for stage I non-small cell lung cancerclinical stage I non-small cell lung cancerJPRN-UMIN000003797Gunma University Heavy Ion Medical Center37
已完成
不适用
Feasibility study of Carbon-Ion Radiotherapy for Re-Irradiation of Locoregionally Recurrent Head and Neck Tumorsrecurrent head and neck tumorsJPRN-UMIN000033862Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology48
已完成
不适用
Carbon-ion radiotherapy for solitary lymph node recurrence: a retrospective multicenter observational studySolitary lymph node recurrenceJPRN-UMIN000027300Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology323
已完成
不适用
Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Multicentric Phase II StudyHead and neck squamous cell carcinoma at stage III and IVJPRN-C000000306Department of Otorhinolaryngology and Head and Neck Surgery, Osaka University School of Medicine150